EnhydrisPECorp

Long/short equity, research analyst, biotech, healthcare
EnhydrisPECorp
Long/short equity, research analyst, biotech, healthcare
Contributor since: 2012
Company: Daily Biotech
10/8/14
EnhydrisPECorp
Sunesis Pharmaceuticals, Inc. Craters On Negative VALOR Data. Stock Is Now A Terminal Short $SNSS http://seekingalpha.com/a/1ik2t
8/25/14
EnhydrisPECorp
Solid Management And Robust Balance Sheet Point To Large Upside For Prothena $PRTA http://seekingalpha.com/a/1ghrj
8/22/14
EnhydrisPECorp
Sunesis Pharmaceuticals, Inc. Offers A Moderate Risk 80% Return On The Short Side $SNSS http://seekingalpha.com/a/1gbll
8/18/14
EnhydrisPECorp
MannKind Corp. And The Folly Of Cult Biotech Stocks http://seekingalpha.com/a/1g409
8/11/14
EnhydrisPECorp
Enanta Pharmaceuticals Is Simply Too Cheap To Ignore $ENTA http://seekingalpha.com/a/1fo1t
3/10/14
EnhydrisPECorp
Evidence For And Against A Biotech Bubble $GILD http://seekingalpha.com/a/18jj1
3/6/14
EnhydrisPECorp
Galena Biopharma: The Legal Stakes Are Rising $GALE http://seekingalpha.com/a/18eh3
3/4/14
EnhydrisPECorp
Clearing The Air On Galena's Legal Woes $GALE http://seekingalpha.com/a/18b7v
3/3/14
EnhydrisPECorp
Did Galena Biopharma Mislead Investors And Patients About NeuVax? $GALE http://seekingalpha.com/a/1885l
3/4/14
Yeah, it was old quite a few 'articles' ago. Seems though, currently, the short articles aren't doing much to bring the price down.
3/4/14
We have come to a middle ground now. Now it's really left up to the science behind the drugs and company management.
2/20/14
EnhydrisPECorp
Prana Biotechnology And MannKind Corp: Bad News Obeys Its Own Special Laws $MNKD, $PRAN http://seekingalpha.com/a/17jh7
2/20/14
always a damn fact! GL
2/20/14
This was a phaseIIa trial, the primary endpoint was SAFETY not efficacy. You should try READING
2/14/14
EnhydrisPECorp
A Deeper Look At The Galena Biopharma Controversy $GALE http://seekingalpha.com/a/17c3x
When you have a vested interest by shorting a stock, you have zero credibilty!
Short articles have just as much power manipulating the stock than long ones on SA. Theses shorters are making money off their articles.
2/13/14
EnhydrisPECorp
Chelsea Therapeutics: The Good, The Bad And The Ugly $CHTP http://seekingalpha.com/a/178wx
2/10/14
EnhydrisPECorp
Ariad Pharmaceuticals: Long-Term Prospects Of The Biotech Beauty Contest $ARIA http://seekingalpha.com/a/170tj
2/4/14
EnhydrisPECorp
Dear Healthcare Investors: The Correction, It's Here http://seekingalpha.com/a/16o37
I tweeted several times in last month the foll "Dev-Stage Biotech Cmpnies in a HUGE BUBBLE". Eg: $ANAC $PVCT $GALE
1/30/14
EnhydrisPECorp
Vringo: How To Lose At Winning $VRNG http://seekingalpha.com/a/16fwh
1/30/14
Your article is so true, Go Long VRNG !
1/30/14
I think article's title needs to be corrected.sends a wrong message.
1/28/14
EnhydrisPECorp
Is The Healthcare Sector Pulling Back Or Crashing? http://seekingalpha.com/a/169i7
1/17/14
EnhydrisPECorp
Why MannKind Is My 2014 Short Pick In Healthcare $MNKD http://seekingalpha.com/a/15sjd
1/17/14
There will certainly be a run up to the April announcement that will far exceed the attempted hack-jobs in recent articles
1/19/14
The would be first and last pharma stock I'll ever invest in if MNKD doesn't get approval. $1 billion plus invested in development
1/13/14
EnhydrisPECorp
The Next Home Run In Healthcare $ICPT http://seekingalpha.com/a/15mbh
1/22/14
Why has OCRX dropped so much Jan. 22? There is no info.
1/10/14
EnhydrisPECorp
Buyout Picks In Healthcare For 2014 http://seekingalpha.com/a/15jlz
1/9/14
EnhydrisPECorp
Healthcare Picks By Drug Type In 2014 http://seekingalpha.com/a/15i1l
1/7/14
EnhydrisPECorp
Health Care Stocks To Avoid This Year $ACAD http://seekingalpha.com/a/15eu1
1/6/14
EnhydrisPECorp
Positioning For 2014 In The Health Care Sector http://seekingalpha.com/a/15crl
9/16/12
EnhydrisPECorp
vrng